VRAN: A Canadian Vaccination Information Network

 
   


 


JOIN VRANS NETWORK
MEMBERSHIP

MENINGITIS LINKS

ABOUT MENINGITIS

MENINGITIS VACCINE

CANADIAN PARENTS WORRIED

QUEBEC CAMPAIGN FAILURE

FEAR HITS EDMONTON

A SCARE TOO FAR?

AFRICA & SPAIN

MENINGOCOCCAL DUE TO A NOVEL SEROGROUP C CLONE

ARTICLES & LINKS

GENERAL ISSUES

ANAPHYLAXIS

ARTICLES OF INTEREST

AUTISM

DOCTORS FOR VACCINE TRUTH

HISTORICAL

MERCURY /THIMEROSAL

SHAKEN BABY

SIDS /CRIB DEATH

VITAMIN C

VACCINE INJURY COMPENSATION

VACCINE INGREDIENTS

ANIMAL HEALTH & VACCINES

SPECIFIC VACCINES

ANTHRAX

CHICKEN POX

DIPHTHERIA, TETANUS, & PERTUSSIS

HEPATITIS-B

HUMAN PAPILLOMAVIRUS

INFLUENZA

MENINGITIS

MEASLES, ,MUMPS, RUBELLA (MMR)

PNEUMOCOCCAL

POLIO

ROTAVIRUS

SMALLPOX

FOR YOUR CONVENIENCE


Download the latest Acrobat Reader to read VRAN's pdf files

NEED TO READ OUR PDF FILES? GET THE LATEST VERSION NOW.

Your VRAN Membership or Literature purchases can be made through PayPal

Free Web Page Hit Counters
 Free Web Site Counter


Online Degrees

VACCINES:    MENINGITIS - FROM VACCINATION  L 'OVERDOSE

MENINGITIS

By Sylvie Simon, Editions Deja
Reprinted in Lifeforce Magazine (summer 1999)

If, in the fight against cancer, we have not advanced as far as in other fields, it is possibly because we are too attached to Pasteurian theories. Are these viruses outside us? Could they not come from our traumatised bodies? (Professor Jean Bernard)

The meningococcus, neisseria meningitidis, is responsible for septicaemia and, particularly, meningitis. A third of meningitis cases are due to meningococcus A, B or C, the latter being the most dangerous in its effects. In total the cases amount to only 400 p.a. but nearly 10 per cent are fatal. Antibiotics are effective but the vaccine, prepared from the bacteria's polysaccharide capsule, does not protect against the B type, the most widespread in France. It is only of relevance to types A and C.

L'lmpatient comments: "The hysteria created every time a meningitis is suspected in a community, particularly among infants, seems out of proportion to the reality. It serves only to justify vaccination of that community even though the vaccine is not compulsory."

Given that as soon as a case is flagged a mass vaccination campaign is undertaken, it is interesting to look at the history of the disease in the countries where it is endemic. In Africa, the Niger and bordering countries are liable to epidemics in November and February. In 1995 Dr Bruno Martin, Adviser to UNICEF at Geneva, stated: "Epidemics come in cycles, every 11-12 years, and it is necessary to foresee their arrival. We need stocks of vaccine because protection is only for 3 years. We vaccinate outside the centre, then towards the centre, to stop propagation."

In fact, an epidemic of cerebro-spinal meningitis hit the Niger (8 million inhabitants) in 1995. Vaccination sessions were organised and in March humanitarian effort had provided 2 million doses. By the 29th of that month 4 million doses had been procured. Dr Marc Vercoutere has studied the official figures:

 

Date Cases Notified Deaths
28 February 2000 233
3 March 5000 500
9 March   529
16 March 8800 874
27 March 10000 1000
23 March 12645 1300
29 March 15000 1500
7 April 22000 2192
23 May 40000 3200

 

And he observes: "You will note the appreciable and constant increase in the epidemic, particularly at the end of March, when the vaccination campaign had virtually ended and protection was supposed to be effective alter 8 days. Despite massive vaccination which, in principle, should have given protection for about 3 years, we counted, in March 1996 after a new epidemic, 341 deaths in 2945 cases. On 8 October 1997, after yet another epidemic (within the supposed Period of vaccine protection), they announced 504 deaths from 4925 cases." Dr Vercoutere noted a slight increase in the deaths-to-cases ratio, which would suggest increasing resistance to the antibiotic treatment, in addition to the inefficacy of the vaccinations. A review of the 1996 epidemic in Nigeria, which killed 8000, provided similar findings.

In September 1997, when Spain had just undertaken a meningitis vaccination programme, the President of the Spanish Society of Paediatricians, Manuel Moya, was opposed to it on the basis that "The vaccination is not effective" and, in any event, "we are nowhere near the 10 cases stipulated by the WHO for mass vaccination." (La Quotidian du Medicin, 29 September 1997.) According to Ignacio Sanchez, president of the doctors' organisation, this measure was "above all a political decision without any foundation in epidemiology.'' (Depeche AFP, International Espagne-Sante, 22 September 1997.) On meningitis vaccination in Spain Le Quotidian du Medicin added: "An expert pharmacist at Madrid's largest hospital did not hide his intention to leave his own infants unvaccinated." The individual was well placed to know what was in the vaccine and was disinclined to expose his children to the associated risk.

When we know that vaccine antigens are nearly all a neurocerebral tropism* the question that arises when a child presents with meningitis is: "Has the child had a vaccination of some sort?" In nature dangerous meningococci do not wander about haphazardly. Vaccinations predispose to more aggressive bacterial strains, which will soon have nothing to fear from all our antibiotics.

*Turning of (part of) particular organism in particular direction in response to external provocation.

Lifeforce magazine from Vaccination Information Subscription (4 issues) £8 waged, £5 unwaged. m:

Vaccination Information (UK)
PO Box 43, Hull HU1 1AA
mailto:yvonne@vaccinfo.karoo.co.uk
website: www.vaccinfo.karoo.net


©2003 Vaccination Risk Awareness Network Inc.  All rights reserved.  
The contents of this publication reflect the opinion of the authors only. This publication is for informational purposes only. Opinions expressed should not be construed as medical advice. The particulars of any person's concerns and circumstances should be discussed with a qualified health care practitioner prior to making any decision which may affect the health and welfare of that individual or anyone under his or her care. 

WebDesign by ComTech Designs - Associates and its licensors